Corbett TH - Search Results

1

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH. LoRusso P, et al. Among authors: corbett th. Cancer Res. 1990 Aug 15;50(16):4900-5. Cancer Res. 1990. PMID: 2165850

2

Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.

LoRusso PM, Aukerman SL, Polin L, Redman BG, Valdivieso M, Biernat L, Corbett TH. LoRusso PM, et al. Among authors: corbett th. Cancer Res. 1990 Sep 15;50(18):5876-82. Cancer Res. 1990. PMID: 2393858

3

Activity of batracylin (NSC-320846) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Bissery MC, Valeriote F, Plowman J, Luk GD, Corbett TH. Mucci-LoRusso P, et al. Among authors: corbett th. Invest New Drugs. 1989 Nov;7(4):295-306. doi: 10.1007/BF00173759. Invest New Drugs. 1989. PMID: 2557298

4

Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.

Horwitz JP, Massova I, Wiese TE, Wozniak AJ, Corbett TH, Sebolt-Leopold JS, Capps DB, Leopold WR. Horwitz JP, et al. Among authors: corbett th. J Med Chem. 1993 Nov 12;36(23):3511-6. doi: 10.1021/jm00075a004. J Med Chem. 1993. PMID: 8280289

5

Comparative efficacy of DMP 840 against mouse and human solid tumor models.

LoRusso P, Demchik L, Dan M, Polin L, Gross JL, Corbett TH. LoRusso P, et al. Among authors: corbett th. Invest New Drugs. 1995;13(3):195-203. doi: 10.1007/BF00873800. Invest New Drugs. 1995. PMID: 8729946

6

Preclinical antitumor activity of CI-994.

LoRusso PM, Demchik L, Foster B, Knight J, Bissery MC, Polin LM, Leopold WR 3rd, Corbett TH. LoRusso PM, et al. Among authors: corbett th. Invest New Drugs. 1996;14(4):349-56. doi: 10.1007/BF00180810. Invest New Drugs. 1996. PMID: 9157069

7

Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.

Foster BJ, Wiegand RA, Pugh S, LoRusso PM, Rake J, Corbett TH. Foster BJ, et al. Among authors: corbett th. Clin Cancer Res. 1997 Nov;3(11):2047-53. Clin Cancer Res. 1997. PMID: 9815596

8

Preclinical antitumor activity of XK469 (NSC 656889).

LoRusso PM, Parchment R, Demchik L, Knight J, Polin L, Dzubow J, Behrens C, Harrison B, Trainor G, Corbett TH. LoRusso PM, et al. Among authors: corbett th. Invest New Drugs. 1998-1999;16(4):287-96. doi: 10.1023/a:1006206814025. Invest New Drugs. 1998. PMID: 10426660

9

Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Biernat LA, Valeriote FA, Corbett TH. Mucci-LoRusso P, et al. Among authors: corbett th. Invest New Drugs. 1990 Aug;8(3):253-61. doi: 10.1007/BF00171834. Invest New Drugs. 1990. PMID: 2177044

10

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.

Poondru S, Parchment RE, Purohit V, LoRusso P, Horwitz JP, Hazeldine ST, Polin L, Corbett T, Jasti BR. Poondru S, et al. Invest New Drugs. 2002 Feb;20(1):23-33. doi: 10.1023/a:1014457510073. Invest New Drugs. 2002. PMID: 12003192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters